Alex
At Best Startup Canada we track over 100,000 Canadian startups and over 500,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top Alberta based President operating in the Medical space. If you think a President is missing from this list, feel free to contact our editor on editor@beststartup.ca.
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Haili Wang
Vice President and Chief Scientific Officer of Metabolomic Technologies
Dr. Haili Wang is a colorectal surgeon and Assistant Professor at the University of Alberta Hospital, and has recently completed her Masters degree in Clinical Epidemiology. Her area of research expertise relates to urine metabolomics and colorectal cancer screening. Dr. Wang has presented at numerous clinical and scientific conferences and has an in-depth knowledge of metabolomics and colorectal cancer.
Follow Haili Wang:
About Metabolomic Technologies, Metabolomic Technologies, University of Alberta: Metabolomic Technologies develops patented, metabolomic-based, diagnostic tests to detect adenomatous polyps and colorectal cancer (CRC).
Richard Fedorak
President and Chief Medical Officer of Metabolomic Technologies
Dr. Richard Fedorak is Professor in the Faculty of Medicine, and Interim Dean, Faculty of Medicine and Dentistry, at the University of Alberta. Dr Fedorak is a recognized international expert in gastrointestinal disorders, as well as a recipient of numerous awards and over $35 million in research fellowships and grants. Dr Fedorak serves on multiple national and international scientific advisory boards and has published over 400 peer-reviewed manuscripts.
Follow Richard Fedorak:
About Metabolomic Technologies: Metabolomic Technologies develops patented, metabolomic-based, diagnostic tests to detect adenomatous polyps and colorectal cancer (CRC).
Steve Dobler
President of Aurora Cannabis
Follow Steve Dobler:
About Aurora Cannabis, superior safety codes: Aurora Cannabis is a medical marijuana producer that provides its patients quality products, customer service, and affordable pricing.
Kelly Narine
Vice President, Research of Aurora Cannabis
Kelly Narine is Vice President-Research at Aurora Cannabis, Inc. She received a doctorate from the University of Alberta
Follow Kelly Narine:
About Aurora Cannabis: Aurora Cannabis is a medical marijuana producer that provides its patients quality products, customer service, and affordable pricing.
Alim Mitha
Co-founder, President, & Chief Technology Officer of Fluid Biotech
Follow Alim Mitha:
About Fluid Biotech: Fluid Biomed is a Calgary based company that aims to develop the next generation of stents to improve patient well-being.
Ravi Jahagirdar
Vice President, Pharmacology, Toxicology and Safety of Zenith Epigenetics
Ravi is the Senior Director of Pharmacology. Ravi has a strong background in animal, lipid/lipoprotein physiology and manages all discovery in vivo pharmacology related to autoimmune and oncology programs at Zenith. Ravi has over 17 years of experience from both academia and industry in in-vivo pharmacology, animal physiology, drug discovery, early toxicology and pharmacokinetic studies, basic research, assay development and high throughput screening. He has been successful in recruiting scientists, building departments and managing projects from early discovery to pre-clinical development and business collaborations. Ravi has strong interpersonal and leadership skills developed through several years of teaching, training and management experience. Ravi received his Doctor of Veterinary Medicine in Bangalore and a MS in Molecular Biology/Microbiology from Health Sciences Center (MUN, Newfoundland). Prior to joining Zenith, Ravi was department head of Pharmacology at Resverlogix. Prior to Resverlogix Ravi held positions of increasing responsibility at University of Regina, and Tularik Inc. Ravi’s research has been published in many peer reviewed journals and has co-authored a text book chapter and has numerous abstract presentations.
Follow Ravi Jahagirdar:
About Zenith Epigenetics: Zenith Epigenetics is a research and development biotechnology company focused on new and innovative drugs.
Henrik Hansen
Senior Vice President of Operations of Zenith Epigenetics
Henrik Hansen has more than 15 years of experience, from both academia and industry, in basic research, drug discovery, and drug development. His areas of expertise include medicinal chemistry, carbohydrate chemistry, high throughput synthesis, process development, and manufacturing of drug substances and drug products under Good Manufacturing Practices (GMPs) for clinical use. Henrik has held a number of positions within Zenith and am currently Senior Vice President of Operations with responsibility for Project Management, Intellectual Property, CMC, Quality Assurance, and the Medicinal Chemistry Program. Henrik holds a M.Sc. in Chemical Engineering from the Technical University of Denmark and a Ph.D. in Organic Chemistry from Lund University, Sweden. He has authored or co-authored more than 40 articles and meeting abstracts and is listed as an inventor of 9 patent families.
Follow Henrik Hansen:
About Zenith Epigenetics: Zenith Epigenetics is a research and development biotechnology company focused on new and innovative drugs.
Jayan Nagendran
Vice President & Director of Clinical Investigation of Tevosol
Dr. Jayan Nagendran, Chief Medical Officer, is a cardiac surgeon clinician-scientist, and the Surgical Director of Lung Transplantation at the University of Alberta, and the Director of Research for the Division of Cardiac Surgery at the Mazankowski Alberta Heart Institute. He received his doctorate in Experimental Medicine through the Department of Medicine at the University of Alberta in 2009. Dr. Nagendran completed his residency in cardiac surgery at the University of Alberta, and then received sub-specialty training in heart and lung transplantation at Stanford University from 2009-2011. Dr. Nagendran joined the Department of Surgery at the University of Alberta in 2011 and since 2017 is an Associate Professor in the Department of Surgery. In February 2020, Dr. Nagendran and Tevosol won the NASA iTech Ignite the Night award at Tampa. Also, in October 2020, Dr. Nagendran and Tevosol were also chosen as Cycle I Forum Finalists at NASA iTech. He has authored over 100 peer-reviewed manuscripts and holds numerous peer reviewed grants in support of his research projects while also participating as a peer-reviewer to major transplant journals including the Journal of Heart and Lung Transplantation, the American Journal of Transplantation, and Nature Communications.
Follow Jayan Nagendran:
About Bridge to Life Ltd., Tevosol: Tevosol, a medical device company, has develop the Ex-Vivo Organ Support System to increase the number of available organs for transplant.
Gilles Gagnon
President & CEO of Ceapro
Follow Gilles Gagnon:
About Ceapro: Ceapro is into developing functionally active ingredients derived from oats and renewable plant resources for healthcare and cosmetic needs.
Christopher Micetich
President and CEO of Fedora Pharmaceuticals
Christopher Micetich is the President, CEO, and Founder of Brass Dome Ventures Ltd..
Follow Christopher Micetich:
About Creative Destruction Lab (CDL), Fedora Pharmaceuticals: Fedora Pharmaceuticals engages in the discovery and development of antibiotics for life-threatening microbial drug resistance needs.
Cameron Schuler
President, CEO & Co-Founder of VibeDx
Cameron Schuler is the President & CEO of VibeDx. He was formerly an Executive-in-Residence with TEC Edmonton, specializing in medical devices, healthcare and industrial technologies. Cameron’s multi faceted career has covered finance, business & product development, consumer products, IT and general management from start-ups to mature companies. His industry experience includes Alternative Energy, Banking, Consumer Goods, Information Technology (Consumer and Enterprise), Investment Sales and Trading, Life Sciences, Manufacturing, Medical Devices, Nutraceuticals, Oil & Gas, and Oil & Gas Services. Cameron’s roles have included COO, CFO, President and CEO and was COO & CFO of a food manufacturer whose products lead to sales of over 200 million units. Cameron was the Managing Director & Co-Founder of Schuler Law Group, a boutique tax planning law firm. He attained an MBA from Queen’s University and is a Certified Investment Manager and Fellow of the Canadian Securities Institute.
Follow Cameron Schuler:
About VibeDx: VibeDx develops tools to diagnose back problems.
GIPHY App Key not set. Please check settings